Background

Many older persons use the thyroid hormone levothyroxine which is often continued for life. Scientifically, there is much uncertainty whether simple continuation is the optimal approach. First, the physical need for levothyroxine can decrease with age thereby posing a higher risk of overtreatment and adverse effects. Second, large trials in subclinical hypothyroidism have shown no benefit for the use of levothyroxine. Interestingly, guidelines do not address re-evaluation of the indication. This self-controlled trial aims to determine the effects of discontinuation of levothyroxine treatment in older adults.

Methods and analysis

Participants are community-dwelling subjects aged ≥60 years using levothyroxine continuously at a stable dosage of ≤150 µg and a level of thyroid-stimulating hormone (TSH) <10 mU/L. After a control period of 12 weeks, levothyroxine treatment is discontinued gradually using a stepwise approach with regular monitoring of thyroid function guided by their GP. The primary outcome is the proportion of participants withdrawn from levothyroxine while maintaining a free T4 level within the reference range and a TSH level <10 mU/L, 52 weeks after the start of discontinuation. Secondary outcomes are compared with the control period (self-controlled) and include among others, the effects on thyroid-specific and general health-related quality of life. Furthermore, patients' attitudes towards deprescribing and regret regarding discontinuing levothyroxine treatment will be recorded. A total of 513 participants will be recruited to estimate the expected proportion of 50% with a 95% CI ranging from 45% to 55%.

Ethics and dissemination

Approval was obtained from the institutional Medical Ethics Committee. The Older People Advisory Board Health and Well-being has reviewed the research proposal and their comments were used for improvement. In line with the funding policies of the grant organisation funding this study, the study results will be proactively disseminated to the general public and key public health stakeholders.

Trial registration number

NL7978; NCT05821881.

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.

Overview publication

TitleEffects of discontinuation of levothyroxine treatment in older adults: protocol for a self-controlled trial.
DateApril 25th, 2023
Issue nameBMJ open
Issue numberv13.4:e070741
DOI10.1136/bmjopen-2022-070741
PubMed37185193
AuthorsRavensberg AJ, Poortvliet RKE, Du Puy RS, Dekkers OM, Mooijaart SP & Gussekloo J
KeywordsAged, GENERAL MEDICINE (see Internal Medicine), GERIATRIC MEDICINE, PRIMARY CARE, Quality of Life, Thyroid disease
Read Read publication